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STING is an ER-associated membrane protein that is
critical for innate immune sensing of pathogens.
STING-mediated activation of the IFN-I pathway
through the TBK1/IRF3 signaling axis involves both
cyclic-dinucleotide binding and its translocation
from the ER to vesicles. However, how these events
are coordinated, and the exact mechanism of STING
activation, remain poorly understood. Here, we found
that theShigella effector protein IpaJ potently inhibits
STING signaling by blocking its translocation from
the ER to ERGIC, even in the context of dinucleotide
binding. Reconstitution using purified components
revealed STING translocation as the rate-limiting
event in maximal signal transduction. Furthermore,
STING mutations associated with autoimmunity in
humans were found to cause constitutive ER exit
and to activate STING independent of cGAMP
binding. Together, these data provide compelling
evidence for an ER retention and ERGIC/Golgi-
trafficking mechanism of STING regulation that is
subverted by bacterial pathogens and is deregulated
in human genetic disease.
INTRODUCTION
Vertebrates are constantly facing challenges from pathogenic
microbes. To counter this, eukaryotic cells express pattern-
recognition receptors that detect microbes through pathogen-
associated molecular patterns (PAMPs), which then activate
interferon (IFN) and proinflammatory responses. One important
protein that plays a central role in sensing a wide variety of cyto-
solic pathogens is STING. STING plays a key role in innate
immune sensing of cytosolic DNA and cyclic dinucleotides (Bur-
dette et al., 2011; Cai et al., 2014). DNA produced by retrovirus
(e.g., HIV-1; Gao et al., 2013; Yan et al., 2010) and DNA viruses
(e.g., Herpes simplex virus; Ishikawa et al., 2009) are recognized
by cGAS, which converts ATP and GTP to the second
messenger 2030 cyclic GMP-AMP (cGAMP) (Li et al., 2013).Cell HoscGAMP directly activates STING through a mechanism that is
still poorly understood. In addition, cyclic dinucleotides associ-
ated with bacterial infection (e.g., Listeria monocytogenes; Bur-
dette et al., 2011) can also activate STING, providing a broad
immunological sensor for host defense against remarkably
diverse pathogen types.
In context of normal physiology, STING activation needs to
be carefully regulated as constitutive or chronic activation due
to genetic mutations are associated with autoimmune and
autoinflammatory disorders (Hasan et al., 2013; Liu et al.,
2014). For example, several gain-of-function mutations in
TMEM173 (encodes STING) were found in patients with an auto-
inflammatory disease called STING-associated vasculopathy
with onset in infancy (SAVI) (Liu et al., 2014) and more recently
in patients with lupus-like syndromes (Jeremiah et al., 2014).
The molecular mechanisms of these diseases are unclear,
although constitutive activation of STING signaling is likely
involved. Thus, elucidating STING activation mechanism is of
great importance in understanding both microbial pathogenesis
and autoimmune disorders.
Previous studies indicated that STING activation involves traf-
ficking from the ER to autophagic-like vesicles (Ishikawa et al.,
2009) and the phosphorylation of TBK1 and IRF3, leading to
NF-kB and IFN gene expression (Burdette and Vance, 2013).
Despite the importance of these atomic models for revealing
conformational changes induced by cyclic dinucleotide ligand
binding, the structure have offered very few clues on the mech-
anism of STING activation (Burdette and Vance, 2013; Zhang
et al., 2013). Here, we took advantage of two recently character-
ized Shigella Type 3 secretion system (T3SS) effector proteins,
IpaJ and VirA, that uniquely target different steps of the host
secretory pathway (Burnaevskiy et al., 2013) and engineered
several deletion and chimeric bacterial strains that are capable
of ‘‘pausing’’ STING trafficking and signaling at intermediate
stages during an ongoing infection. We found that Shigella
effector IpaJ inhibits STING activation by blocking its transloca-
tion from ER to ER-Golgi intermediate compartments (ERGIC), a
complex system of tubulovesicular membrane clusters found
near ER exit sites. We also found that STING-mediated TBK1/
IRF3 activation reaches themaximum at the ERGIC. Importantly,
we found that STING disease-associated mutants cause consti-
tutive ER exit, stably associate with ERGIC and Golgi, and acti-
vate STING signaling independent of cGAMP binding. Thus, ourt & Microbe 18, 157–168, August 12, 2015 ª2015 Elsevier Inc. 157
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Figure 1. Shigella Effector IpaJ Inhibits STING-Mediated IFN Activation
(A) Quantitative RT-PCR analysis of Ifnb mRNA in MEFs infected with indicated Shigella strains for 8 hr. Individual gene expression value was normalized to
housekeeping gene Gapdh (same throughout).
(B) Quantitative RT-PCR analysis of Ifnb mRNA in MEFs infected with Shigella WT or DipaJ at indicated MOI for 8 hr.
(C) Quantitative RT-PCR array analysis of immune gene expression (indicated on the right) in MEFs infected with various Shigella strains (indicated on the top).
(D) Quantitative RT-PCR analysis of Tnf mRNA in MEFs infected with indicated Shigella strains for 8 hr as in (A).
(E) Quantitative RT-PCR analysis of IfnbmRNA in siRNA knockdown MEFs infected with ShigellaWT or DipaJ. MEFs were transfected with indicated siRNA and
two days later were infected with Shigella WT or DipaJ. Ifnb mRNA was measured 8 hr after infection.
(F) Quantitative RT-PCR analysis of IfnbmRNA in WT or knockout MEFs (indicated on the bottom) infected with ShigellaWT or DipaJ. *p < 0.05, **p < 0.01, and
***p < 0.001 (same throughout). Data are representative of at least three independent experiments. Error bars, SEM. Unpaired t test.findings provide a spatial model for STING activation and critical
insights on the pathogenesis of STING diseases.
RESULTS
Shigella flexneri Antagonizes STING-Mediated IFN
Activation
Shigella flexneri is a Gram-negative bacterial pathogen that
utilizes a T3SS to inject effector proteins that regulate innate
immune signaling pathways (Raymond et al., 2013; Reddick
and Alto, 2014). Because Shigella invades non-phagocytic cells,
escapes the vacuole, and replicates in the host cytoplasm, it was
reasonable to think that it would be recognized by cytosolic im-
mune receptors such as cGAS and activate STING signaling.
Shigella flexneriM90T (hereafter Shigella) infection in mouse em-
bryonic fibroblasts (MEFs) induced a modest increase in IFNb
expression that was not observed in the non-invasive Shigella
DmxiD strain (an essential component of the Mxi/Spa T3SS).158 Cell Host & Microbe 18, 157–168, August 12, 2015 ª2015 ElseviWe next tested if immune regulatory T3SS effectors may
dampen the Type I IFN response. Because STING trafficking
from the endoplasmic reticulum (ER) is essential to its activation
mechanism, we performed loss-of-function genetic studies
focusing on Shigella effectors IpaJ and VirA that inhibit Golgi
apparatus structure and function (Burnaevskiy et al., 2013;
Dong et al., 2012). As shown in Figure 1A, ShigellaDipaJ strain
induced a 10-fold increase in IFNb expression compared to
wild-type (WT) Shigella. This finding was consistent over 2-log
range of bacterial challenge, indicating that host cells respond
to cytosolic Shigella in a dose-dependent manner and that
IpaJ dampens the immune response even at high burdens of
infection (Figure 1B). IFN-stimulated genes (ISGs) were also
highly induced in ShigellaDipaJ-infected cells, whereas there
was little change in inflammatory transcripts likely induced by
LPS (Figures 1C and 1D).
To then determine if the Type I IFN response to Shigella infec-
tion depended on the STING-TBK1-IRF3 signaling axis, theer Inc.
expression of each signaling component was depleted in cells.
ShigellaDipaJ-induced IFNb expression was significantly
reduced in cells treated with RNAi targeting STING, TBK1, and
IRF3 (Figure 1E) and was almost completely eliminated in
cGAS/, Sting-gt/gt, or Irf3/ MEFs (Figure 1F). In contrast,
Mavs/, Myd88/Trif/, or Irf7/ had no effect (Figure 1F),
highlighting the specificity of IpaJ at inhibiting cGAS/STING
cytosolic DNA-sensing pathway in this cellular model of infec-
tion. These data also demonstrate that ShigellaDipaJ-induced
IFN response in MEFs is stimulated by bacteria DNA. Recently,
we demonstrated that IpaJ inhibits ER to Golgi transport by
selectively cleaving N-myristoylated glycine of human ARF-fam-
ily GTPases (Burnaevskiy et al., 2013, 2015). This proteolytic
function of IpaJ was conserved in a murine model of cellular
infection (Figure S1). Based on these findings, it was attractive
to hypothesize that Shigella IpaJ inhibits STING signaling at the
level of ER to Golgi transport. Interestingly, however, the Shigella
T3SS effector VirA also inhibits cargo transport through the Golgi
apparatus, a phenotype dependent on its ability to stimulate GTP
hydrolysis on Rab1 GTPase (Dong et al., 2012). Unexpectedly,
cells infected with ShigellaDvirA strain exhibited low levels of
IFNb and ISG expression comparable to cells infected with WT
Shigella strain, whereas ShigellaDipaJ and ShigellaDipaJ/virA
induced a robust IFN response (Figures 1A and 1C). These
data provide compelling evidence that STING signal transduc-
tion can be discriminated at the level of ARF and Rab GTPase
regulation.
Reconstitution of IFN Regulation in a Listeria Model
of STING Activation
Since Shigella secretes a large number of effector proteins into
host cells, it is difficult to draw unequivocal conclusions about
the role of IpaJ using this infection models (Figure 2A). Listeria
monocytogenes (hereafter referred to as Listeria) is a Gram-pos-
itive bacterial pathogen that directly activates STING by
secreting c-di-AMP into the host cytosol (Burdette et al., 2011;
Witte et al., 2012;Woodward et al., 2010) (Figure 2A).While these
two evolutionarily unrelated bacterial pathogens exhibit intracel-
lular life cycles, Listeria neither encodes homologs of ipaJ or virA
nor disrupts ER-to-Golgi trafficking (Burnaevskiy et al., 2013). To
then verify that IpaJ truly inhibits STING signaling in the context
of a well-established activation mechanism, we engineered the
human-attenuated Listeria vaccine strainDactA to secrete exog-
enous Shigella effector proteins into the cytosol of infected
target cells. This was accomplished by fusing the promoter
and the Type II secretion sequence (residues 1–100) of actA to
the protease domain of ipaJ and ipajC64A (Figure 2A) or the
GAP domain of virA (see Experimental Procedures). These chi-
meras were recombined into the genome of ListeriaDactA (Lauer
et al., 2002). In principle, the Shigella T3SS effector proteins
should be expressed, as Listeria escapes the vacuole and enters
the host cell cytoplasm due to cytosolic stimulation of the actA
promoter, and subsequently secreted by the Type II Secretion
System (due to theActA signal sequence). As shown in Figure 2B,
ListeriaDactA::ipaJ and ListeriaDactA::virA disrupted Golgi ar-
chitecture at early stages of infection, indicating these Shigella
effectors are functional when produced by Listeria. The engi-
neered Listeria strains also invaded host cells and replicated
to similar levels as the ListeriaDactA parent strain (Figure 2C).Cell HosTo then assess the role of ER to Golgi transition on a natural
route of STING activation, we infected WT MEFs with Listeria
strains and assessed STING activation by measuring IFNb
expression (Figure 2D). Compared to ListeriaDactA, cells in-
fected with ListeriaDactA::ipaJ exhibited significantly lower
IFNb gene expression, whereas neither ListeriaDactA::virA nor
ListeriaDactA::ipaJC64A chimeras inhibited IFNb expression.
Consistent with the notion that STING inhibition occurred by pro-
teolytic demyrstoylation of ARF1, ListeriaDactA::ipaJ induced
the removal of GFP-ARF1 from Golgi membranes, whereas
neither ListeriaDactA::ipaJC64A nor ListeriaDactA::virA disrup-
ted ARF1 localization (Figure S2). Together, these findings
confirm the STING inhibitory function of IpaJ in a well-defined
model of microbial immune regulation.
Maximum STING Activation on the ERGIC
The differential regulation of STING activation by bacteria
secreting IpaJ or VirA suggests that subtle differences in ARF1
and Rab1 GTPase regulation at the ER to Golgi transition
have profound consequences on immune signal transduction.
These differences may shed light on the enigmatic activation
mechanism of STING. To examine cytosolic dsDNA-stimulated
STING trafficking in precise spatial and temporal resolution, we
reconstituted the fundamental aspects of bacterial infection us-
ing purified components and a surrogate microinjection system
(Figure 3A). To visualize STING activation at the level of ER trans-
port in single cells, mouse STING-GFPwas stably integrated into
the genome of Sting/ MEFs. As expected, STING-GFP local-
ized to the ER in quiescent cells and rapidly transported to
vesicles upon activation of cGAS by microinjected purified
Shigella genomic DNA (herein dsDNA) (Figure 3A). Next, dsDNA
was mixed with purified recombinant IpaJ or VirA, loaded into
the micropipette, and microinjected into the cytoplasm of
STING-GFP cells (Figure 3A). IpaJ effectively arrested STING
trafficking out of the ER even in presence of high concentrations
of dsDNA. This trafficking defect was due to proteolytic demyr-
istoylation of ARF GTPases, since recombinant IpaJ C64A
failed to block STING trafficking. Interestingly, STING-GFP
exited from the ER, but its transport was arrested at the ERGIC
in cells microinjected with VirA and dsDNA. Because VirA does
not inhibit the IFN response (Figure 1A), it now appears the
STING activation occurs immediately after ER exit and its transi-
tion into the ERGIC. Consistent with these reconstitution studies,
ShigellaDipaJ infection activated substantial STING exit from the
ER, whereas WT Shigella infection arrested STING-GFP on the
ER (Figures 3B and S3). Activated STING in ShigellaDipaJ-in-
fected cells localize to intermediate membrane compartments
as shown by colocalization with both ERGIC and cis-Golgi
markers (P58 and GM130, respectively). Thus, STING activation
directly correlates with its ER to ERGIC/Golgi transition (Figures
3B and S3).
To then determine if STING transduces signal from the inter-
mediate membrane compartments, we measured TBK1/IRF3
phosphorylation and TBK1 recruitment to STING. In control ex-
periments, transfection of dsDNA induced IRF3 and TBK1 phos-
phorylation that peaked at 2–4 hr and dissipated over the next
24 hr (Figure 4A), similar to those previously described (Burdette
and Vance, 2013). Endogenous TBK1 normally distributed
throughout the cytoplasm was recruited to STING-GFP-positivet & Microbe 18, 157–168, August 12, 2015 ª2015 Elsevier Inc. 159
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Figure 2. Listeria/ipaJ Chimeric Bacteria Infection Blocks STING Signaling
(A) A schematic diagram of Shigella subversion and Listeria activation of the STING pathway (left) and Listeria chimera design for expressing Shigella
effectors (right).
(B) Fluorescent microscope of HeLa cells infected with indicated Listeria strains. The cis-Golgi (red) was detected by a-GM130 antibody. Arrows indicate
disrupted Golgi apparatus.
(C) Bacteria load in MEFs infected with indicated Listeria strains in a time course.
(D) Quantitative RT-PCR analysis of Ifnb and Tnf mRNA in MEFs infected with indicated Shigella strains for 8 hr. Data are representative of at least three
independent experiments. Error bars, SEM. Unpaired t test (D). See also Figure S2.vesicles upon dsDNA transfection as expected (Figure 4C).
Interestingly, we found that TBK1 was recruited to STING
at intermediate membrane compartments in ShigellaDipaJ-
infected cells (Figure 4D), further supporting that STING is active
on these intermediate membrane compartments. We also
observed stronger phosphorylation of both TBK1 and IRF3 in
ShigellaDipaJ-infected cells compared to WT Shigella-infected
cells (Figure 4B). Conversely, ListeriaDactA::ipaJ infection160 Cell Host & Microbe 18, 157–168, August 12, 2015 ª2015 Elseviinduced less TBK1 and IRF3 phosphorylation compared to
ListeriaDactA infection (Figure 4E). These data are consistent
with stronger IFN expression induced by ShigellaDipaJ infection
(compared to WT) and by ListeriaDactA infection (compared to
ListeriaDactA::ipaJ) (Figures 1A and 2D), and with IpaJ blocking
STING-mediated IFN activation. Of note, we consistently
detected low level of IFN activation and TBK1 and IRF3 phos-
phorylation in WT infected cells compared to uninfected or toer Inc.
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Figure 3. Reconstituting Cytosolic DNA Sensing through Microinjection
(A) Fluorescent micrographs show STING-GFP localization in MEFs after microinjection. STING-GFP MEFs were microinjected with buffer alone, DNA alone, or
DNA plus recombinant effector proteins (indicated on the left). Cells were fixed 6 hr later and co-strained with an ERGIC marker, ERGIC/p58 (in red). * marks
injected cells. Schematic models of STING localization under various conditions are shown on the right. Quantitation is shown below (n = 30).
(B) Fluorescent micrographs show STING-GFP localization in MEFs after DNA transfection or Shigella infection. STING-GFP MEFs were left untreated, trans-
fected with HT-DNA, or infected with Shigella WT or DipaJ. Cells were fixed 8 hr later and co-stained with ER (Calnexin), ERGIC (P58), or Golgi (GM130).
Schematic models of STING localization under various conditions are shown on the right. Quantitation of colocalization was calculated as Pearson’s correlation
coefficient (r) shown below (n = 15). Images are representative of at least three independent experiments. See also Figure S3.DmixD that does not infect host cells (data not shown), despite
the presence of both IpaJ and VirA in the WT strain. Neverthe-
less, these spatial and biochemical analysis of STING demar-
cates ERGIC as a primary cellular location for peak STING signal
transduction.
To examine the kinetics of STING trafficking after DNA trans-
fection or bacterial infection, we also performed live-cell timeCell Hoslapse microscopy (DNA transfection) using STING-GFP cells
as well as fixed-cell time course (Shigella infection) (Movie S1;
Figure S4A). We found that DNA transfection caused strong
activation of STING trafficking, and STING moved from the ER
to vesicles in 90 min (Figure S4A). In contrast, ShigellaDIpaJ
infection promoted STING translocation from the ER to ERGIC/
Golgi by 6 hr post-infection (Figure S4B). The slower kinetics oft & Microbe 18, 157–168, August 12, 2015 ª2015 Elsevier Inc. 161
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Figure 4. STING Signaling Kinetics and
Activation on ERGIC
(A and B) Immunoblots show kinetics of IRF3 and
TBK1 phosphorylation in MEFs after HT-DNA
transfection (A) or Shigella infection (B).
(C and D) Fluorescent micrographs show STING-
GFP and endogenous TBK1 localization in MEFs
after DNA transfection (C) or Shigella infection (D).
MEFs were transfected or infected as in Figure 3B.
Cells were fixed 8 hr later and co-stained with an
TBK1 antibody. Quantitation of colocalization was
calculated as Pearson’s correlation coefficient (r)
shown below.
(E) Immunoblots show kinetics of IRF3 and TBK1
phosphorylation in MEFs after infection of indi-
cated Listeria strains. Data are representative of at
least three independent experiments. See also
Figure S4.STING trafficking after Shigella infection is likely due to the very
small amount of DNA introduced by bacterial infection
comparing to DNA transfection (1 mg).
We showed previously that nocodazole prevents membrane
trafficking beyond ERGIC in a manner analogous to Rab1 inhi-
bition by the VirA homolog EspG (Selyunin et al., 2014). Brefel-
din A (BFA) potently inhibits ARF1 GTPase and can therefore be
considered ‘‘IpaJ like.’’ To then confirm previous results (Ishi-
kawa et al., 2009) that BFA inhibits STING signaling in our
model system, we treated MEFs with increasing doses of BFA
or nocodazole for 1 hr and transfected DNA to activate STING
signaling and IFN expression. BFA inhibited DNA-induced IFN
activation in a dose-dependent manner (Figures S4C and
S4D). Interestingly, nocodazole only marginally affected DNA-
induced IFN activation (Figures S4C and S4D). These data
further suggest that STING activation does not require the full
extent of membrane trafficking pathway and are consistent
with maximum STING activation on intermediate membrane
compartments.162 Cell Host & Microbe 18, 157–168, August 12, 2015 ª2015 Elsevier Inc.Disease-Associated STING
Mutations Cause Constitutive ER
Exit Leading to Ligand-Independent
STING Activation
Our findings suggest a two-step activa-
tionmechanism that first involves cGAMP
binding to ER-localized STING and that
second involves STING transport from
the ER to ERGIC. The observation that
IpaJ inhibited STING signal transduction
by blocking its transport out of the ER in
the presence of high levels of cGAMP
(produced by dsDNA) or cyclic di-AMP
(secreted by Listeria) suggests that nucle-
otide binding triggers ER exit of STING
and that STING activation of TBK1 results
from its change in subcellular location
(Figure S5A). Recently, the genetic le-
sions of patients exhibiting autoinflam-
matory vasculopathy and autoimmunity
were mapped to single amino acids sub-stitutions in STING. Interestingly, these residues make up a small
linker region connecting the N-terminal transmembrane domain
of STING to the C-terminal cyclic dinucleotide-binding domain,
away from the cyclic dinucleotide binding pocket (Zhang et al.,
2013). In addition, these substitutions lead to constitutive
TBK1/IRF3 activation and uncontrolled interferon response
(Jeremiah et al., 2014; Liu et al., 2014). We hypothesized that
these residues may play an important role in retaining STING
on the ER in unstimulated cells, and disease mutations disrupt
ER retention resulting STING translocation to the ERGIC, by-
passing the need for cGAMP binding for TBK1/IRF3 activation
(Figure S5B).
To test this two-step model of STING activation in context of
human disease progression, retroviral expression vectors were
used to establish murine STING-GFP or the STING mutants
N153S and V154M (that are highly conserved with humans) in
Sting/ MEFs (Figure 5A). Remarkably, WT STING localized to
the ER as expected whereas disease-associated STING mu-
tants clearly localized to the ERGIC and Golgi in unstimulated
AM
oc
k
S
K
O
/S
TI
N
G
-G
FP
D
N
A
M
oc
k
D
N
AS
K
O
/N
15
3S
-G
FP
ER ERGIC GolgiSting Sting StingMerge Merge Merge
ER ERGIC GolgiSting Sting StingMerge Merge Merge
ER ERGIC GolgiSting Sting StingMerge Merge Merge
ER ERGIC GolgiSting Sting StingMerge Merge Merge
3K 10K 25K 50K 100K
3K 10K 25K 50K 100K
SKO/STING-GFP
SKO/N153S-GFP
Golgi (TGN38)
ER (Calnexin)
Sting-GFP
ERGIC (p58)
Golgi (TGN38)
ER (Calnexin)
Sting-GFP
ERGIC (p58)
B
Pe
ar
so
n'
s
co
rre
la
tio
n
co
ef
fic
ie
nt
 (r
)
-0.5
0.0
0.5
1.0
ER
ERGIC
Golgi
Mock DNA Mock DNA
WT N153S
TBK1
TBK1
STING-WT
3K 10K 25K 50K 100K
0
20
40
60
80
100
Membrane fractions
%
of
 p
ea
k 
va
lu
e
WT-TGN
WT-STING
WT-ERGIC
WT-ER
WT-TBK
STING-N153S
Membrane fractions
%
of
 p
ea
k 
va
lu
e
3K 10K 25K 50K 100K
0
20
40
60
80
100
mt-TGN
mt-STING
mt-ERGIC
mt-ER
mt-TBK
Figure 5. Disease-Associated STING Mutants Constitutively Localize to the ERGIC
(A) Fluorescent micrographs show WT mouse STING-GFP or STING-N153S-GFP localization in MEFs. N153S in mouse STING corresponds to N154S disease
mutation in human STING. WT or mutant mouse STING-GFP is stably expressed in Sting/ MEFs using a retroviral vector following by selection. Each re-
constituted MEFs were mock treated or transfected with HT-DNA. Cells were fixed 8 hr later and co-stained with ER (Calnexin), ERGIC (P58), and Golgi (GM130)
markers. Quantitation of colocalization was calculated as Pearson’s correlation coefficient (r) shown below (n = 15).
(B) Membrane fractionation of WT or N153S STING-GFP reconstituted cells by differential centrifugation (see Experimental Procedures for details). Cell organelle
pellets at indicated centrifugation speed (top) were analyzed by immunoblotting. Distribution of WT and N153S STING in relationship to ER, ERGIC and Golgi
markers is shown on the right based on quantitation of immunoblot in ImageJ. Data are representative of at least two independent experiments.cells (Figure 5A). The localization of STING disease mutants on
the ERGIC/Golgi did not change after dsDNA stimulation,
whereas WT STING quickly translocated to post-Golgi vesicles
(Figure 5A). To confirm this localization, we performed mem-
brane fractionation by differential centrifugation (see Experi-
mental Procedures; modified from Ge et al., 2013). We were
able to clearly separate ER from theGolgi proper, with the ERGIC
migrating in-between these fractions (Figure 5B). Consistent with
the fluorescence microscopy images, WT STING co-migrated
with the ER, whereas the disease mutant N153S induced STING
distribution toward ERGIC andGolgi fractions. TBK1 also shifted
toward ERGIC and Golgi fractions in N153S-reconstituted cells,
consistent with its constitutive active state. We also tested the
corresponding human mutations in an IFNb promoter-driven
luciferase reporter (IFN-Luc) assay. All three disease-associated
STING mutants, V147L, N154S, and V155M, but not the WT,
constitutively activated the IFN-Luc reporter (Figure 6A), consis-Cell Hostent with published findings (Jeremiah et al., 2014; Liu et al.,
2014) and further supporting constitutive ER exit as a mecha-
nism for STING activation.
To then test whether cGAMP binding is required for activating
disease-associated STING mutants, we introduced a second
mutation R232A that disrupts cGAMP binding and prevents
STING activation by DNA or cGAMP (Zhang et al., 2013). In tran-
sient transfection studies, all three disease mutants potently
induce IFN-Luc reporter even with a secondary R232Amutation,
providing strong evidence that these disease mutants activate
STING independent of cGAMP binding. We also validated that
human STING-R232A no longer respond to cGAMP stimulation
(Figure 6B). We used 2030-cGAMP to stimulate 293T cells ex-
pressing WT STING, R232A alone, individual disease mutants
alone, or disease mutants with R232A. WT STING, but not
R232A, responded robustly to cGAMP stimulation as shown
previously (Zhang et al., 2013). Disease mutants alone onlyt & Microbe 18, 157–168, August 12, 2015 ª2015 Elsevier Inc. 163
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tants with R232A become completely irresponsive to cGAMP
stimulation (Figure 6B).
Disease CausingMutations in STINGCauseConstitutive
IFN Activation by ERGIC/Golgi Sequestration
A major prediction of these findings is that human disease muta-
tions result in constitutive STING signaling by driving its traf-
ficking from ER to ERCIC (bypassing the need for cGAMP),
whereupon it is activated. To directly test this hypothesis, we
co-expressed IpaJ or IpaJ(C64A) with each STING mutant.
Remarkably, IpaJ completely inhibited STING activation by dis-
ease mutations, whereas enzymatically dead IpaJ(C64A) had no
effect (Figure 6C). Consistent with ARF1-mediating trafficking
as the site of STING regulation, BFA treatment also reversed
disease mutant localization back to the ER (Figure S6B). In con-
trol experiments, IpaJ did not inhibit RNA-stimulated IFN pro-
duction under these conditions (Figure S6A), thereby confirming
ER exit of STING as the primary mechanism of both ligand-
dependent (cGAMP) and ligand-independent (disease muta-
tions) IFN stimulation.164 Cell Host & Microbe 18, 157–168, August 12, 2015 ª2015 ElseviPrevious studies have shown that DNA-activated STING traf-
fics to a post-Golgi vesicle compartment where it is degraded
by an autophagic-like mechanism (Konno et al., 2013). Thus,
another predication from our microscopy and IFN reporter
studies is that STING disease mutants stably associated with
the ERGIC and Golgi would not respond to DNA-mediated
STING degradation. We examined Sting-KO/STING-GFP cells
by fluorescence-activated cell sorting (FACS), and indeed, we
found that DNA transfection reduced WT STING-GFP level
5-fold by 24 hr. Pretreatment with BFA prevented STING-GFP
degradation, consistent with the notion that STING trafficking
is required for degradation. In contrast, DNA transfection of
Sting-KO/STING-N153S-GFP cells did not cause degradation
of the STING disease mutant (Figure 6D). These data reveal an
additional feature of the STING disease mutants—that they not
only activate STING ER exit, but they also stably associate
with intermediatemembrane compartments to prevent degrada-
tion. Collectively, our data provide a molecular explanation for
gain-of-function STING diseases (Figure 6E) and suggest that
blocking ER exit (by IpaJ or BFA) could be potentially useful
therapeutic avenues.er Inc.
DISCUSSION
STING activation involves translocation from the ER to vesi-
cles, although how immune signaling and trafficking are coor-
dinated remains unclear. The combination of experiments
examining the IFN response to bacterial infection and human
disease mutations provides a spatiotemporal model of STING
signaling activation. Our results suggest that Shigella IpaJ
antagonize STING signaling by blocking ER to ERGIC translo-
cation through ARF GTPase demyristoylation. Studies inhibit-
ing Rab1 GTPase by VirA further indicate that maximum STING
activation occurs immediately after its translocation from ER
to ERGIC. Consistent with this idea, constitutively active mu-
tants of STING almost exclusively localize to the ERGIC and
Golgi, from where they activate TBK1/IRF3 and downstream
immune signaling. ERGIC was recently demonstrated as one
of the main membrane sources of autophagosomes (Ge
et al., 2013; Ge and Schekman, 2013). STING-positive vesicles
formed after DNA stimulation also depend on an autophagy-
related process (Konno et al., 2013), and proteins such as
Atg9a, Beclin1, and ULK1 also regulate cytosolic DNA sensing
and STING signaling (Konno et al., 2013; Liang et al., 2014;
Saitoh et al., 2009). Our finding reveals intermediate membrane
compartments such as the ERGIC as a primary organelle site
for STING maximal signal transduction. The traditionally
defined STING activation vesicles are likely the final destination
of STING trafficking after traversing through ERGIC/Golgi as
well as the membrane location for initiating STING degradation
(to turn signaling off). Consistent with this notion, STING
activation by DNA transfection or ShigellaDipaJ/virA infection
allows STING trafficking all the way to vesicles (Movie S1),
thus turning on and then off downstream signaling. In contrast,
STING activation by ShigellaDipaJ infection or disease mutants
arrest STING trafficking on the intermediate membrane com-
partments, allowing it to turn on downstream signaling and
keep it on.
We now propose an ER retention-and-release mechanism of
STING activation (Figure 6E). In support of this mechanism, all
three diseases-associated residues, V147, N154, and V155,
appear to play non-redundant roles in retaining STING on the
ER, and mutation of either one of these residues causes STING
to constitutively localize to the ERGIC and Golgi and activate
downstream signaling. Published STING structures suggested
an ‘‘up-lifting’’ motion of the overall cytosolic domain due to
the ‘‘clamping’’ of cGAMP (Figure S5B). These conformational
changes may disrupt interactions between critical ‘‘ER retention
residues’’ on STING (i.e., diseases-associated residues) and
unknown protein partners on the ER membrane, which would
allow STING to exit the ER and translocate to the ERGIC. There-
fore, we propose that STING normally resides in the ‘‘ER reten-
tion’’ mode and possibly interacting with critical partners on
the ER. Our findings suggest that primary function of cyclic dinu-
cleotide binding to the STING dimer on the ER is to reorient ER
retention residues (potentially disrupting critical interactions)
that would allow translocation from the ER to ERGIC and Golgi.
In the absence of cyclic dinucleotide binding, STING can be
strongly activated by diseasemutations that disrupt ER retention
or by other membrane perturbations that had been previously
reported to trigger the STING signaling pathway without intro-Cell Hosducing DNA or cyclic dinucleotides (Holm et al., 2012; Noyce
et al., 2006).
Our model provides an exciting molecular explanation for
STING diseases, although further questions do remain, including
what proteins on the ER are involved in STING retention, what
features of the intermediate membrane compartments such as
ERGICmake it themost fertile ground for STING signal transduc-
tion, and why disease mutations appear to be stably associated
with the ERGIC and Golgi and are constantly ‘‘on,’’ whereas
dsDNA stimulation activates STING and quickly turns it ‘‘off.’’
Addressing these questions will provide further insights into
the STING activation mechanism and a better understanding
of pathogenesis of microbial infection and STING-associated
immune disorders. The two Shigella effectors, IpaJ and VirA,
are useful tools for dissecting STING signaling through mem-
brane trafficking systems, as we have clearly demonstrated
using a variety of experimental settings including microinjection
of recombinant proteins or infection with engineered loss-of-
function Shigella strains or gain-of-function Listeria strains. Our
study with these engineered bacteria strains also established a
unique example of how the secretory pathway supports dynamic
signaling events beyond its classical role in protein sorting and
distribution. The molecular action of IpaJ can be mimicked in
the future as a novel therapeutic avenue for STING-mediated
autoimmune and autoinflammatory diseases.
EXPERIMENTAL PROCEDURES
Bacterial Strains
WT parental strain for Shigella flexneri strain M90T and all mutant strains
(DIpaJ, DVirA, DIpaJDVirA, and DMxiD) were described in Burnaevskiy et al.
(2013). Listeria monocytogenes DactA mutant parental strain was a kind gift
from Dan Portnoy. For constructing Listeria monocytogenes expressing IpaJ
or VirA, we used previously described site-specific phage integration vector
pPL1, which inserts at ComK attachment site (Lauer et al., 2002). Promoter re-
gion and 100 N-terminal amino acids of ActA were PCR-amplified from Listeria
genome using primers AAAAGAGCTCTGAAGCTTGGGAAGCAG and AAA
AGCGGCCGCACCTTTCTCTGCTTTTGC (SacI and NotI restriction sites are
underlined) and were cloned into pPL1, resulting in pActA N100-pPL1 cloning
vector. IpaJD50 and VirAD26 (50 and 26 N-terminal amino acids are truncated,
respectively) were PCR-amplified (AAAAGCGGCCGCGGGTTGTTTTTTGGC
GAGGAAGCAGATG and ATATGTCGACTTACAAAGCCTCATTAGTTATAACT
ATGGAAAT primers for IpaJ; AAAAGCGGCCGCGAGTTGGAATAAATTGAGT
TTTTGTGACAT and ATATGTCGACTTAAACATCAGGAGATATGATGGCAAAT
primers for VirA) and cloned into pActA N100-pPL1 in frame with N-terminal
region of ActA using NotI and SalI restriction sites. The resulting constructs
were called IpaJD50 - pActA N100 - pPL1 and VirAD26 - pActA N100 -
pPL1. For transformation of Listeria, we prepared electrocompetent cells using
the protocol described previously (Monk et al., 2008). Listeria cells were incu-
bated overnight in brain-heart infusion (BHI) media at 30C without shaking
and were diluted 1:100 in 500 ml of BHI containing 500 mM sucrose (BHIS)
in the morning. Cells were grown to an OD600 of 0.1 and ampicillin was added
to a concentration of 10 mg/ml. The culture was further incubated with shaking
for 2 hr. Cells were then cooled on ice for 10min and centrifuged (5,0003 g for
10min at 4C). Cell pellet was resuspended in 200ml of ice-cold sucrose-glyc-
erol wash buffer (SGWB) (10% glycerol, 500 mM sucrose; pH 7, filtered). Cells
were centrifuged twomore times andwere resuspended in 70ml of SGWB and
in 20 ml of SGWB after the first and the second centrifugations respectively.
Ten mg/ml of filter-sterilized lysozyme was added, and cells were incubated
at 37C for 20 min. Cells were centrifuged (3,000 3 g for 10 min at 4C) and
resuspended in 10 ml SGWB. Cells were centrifuged and resuspended in
SGWB with the final volume of 2.5 ml, and the 50-ml aliquots were frozen at
80C. For transformation a 50-ml aliquot of electrocompetent cells wasmixed
with 1 mg of plasmid DNA, and the mixture was transferred to a chilled 1-mmt & Microbe 18, 157–168, August 12, 2015 ª2015 Elsevier Inc. 165
electroporation cuvette and pulsed at 10 kV/cm. For recovery, the cells
were supplemented with 1 ml of BHIS, transferred into Eppendorf tube, and
incubated statically at 30C for 1.5 hr. The cells were then concentrated by
centrifugation (3,000 3 g for 2 min) into 100 ml, plated on BHI agar containing
7.5 mg/ml of chloramphenicol, and incubated for 3 days at 30C. Individual
Listeria colonies were screened by PCR using either CTCATGAACTAGA
AAAATGTGG and TGTAACATGGAGGTTCTGGCAATC primers to confirm
specific integration (Lauer et al., 2002) or IpaJ/VirA cloning primers to confirm
the presence of the transgenes. Positive clones were selected for frozen
stocks and infection studies.
Cell Culture
Primary WT, STING golden-ticket (gt/gt) (kind gift from Russell Vance),
Sting/ (kind gift from Glen Barber), Mavs/, Myd88/Trif/ (kind gift from
Zhijian ‘‘James’’ Chen), Irf3/, and Irf7/ mouse embryonic fibroblasts
(MEFs) were generated from embryos on embryonic day E15.5. All MEFs
were grown in complete DMEM (Sigma-Aldrich) supplemented with 10%
(v/v) fetal bovine serum (Sigma-Aldrich), 2 mM L-glutamine (Sigma-Aldrich),
10 mM HEPES (Sigma-Aldrich), 1 mM sodium pyruvate (Sigma-Aldrich),
100 U/ml penicillin (Sigma-Aldrich), and 100 mg/ml streptomycin (Sigma-
Aldrich) at 37C and 5% CO2. Prior to infection, MEFs would be plated in a
12-well at 50,000MEF/well in complete DMEMwithout antibiotics for bacterial
infection.
Shigella Infection
Shigella strains were streaked on a BHI agar plate containing 0.3% Congo red
(Sigma-Aldrich) from a frozen stock. A single red colony was picked and used
to start a culture in BHI broth. The culture was grown overnight at 30C and
shaken at 200 rpm. The next day, the overnight culture was restarted by diluting
the overnight culture 1:25 into fresh BHI broth, grown at 37C, and shaken at
200 rpm for approximately 2 hr until the optical density (OD) reached 0.5–0.6.
Once theOD is reached, theShigellawascentrifugedat10,0003g topelletbac-
terial cells. The BHI supernatant was removed, and the cell pellet was washed
twicewith Dulbecco’s PBS (Sigma-Aldrich) to remove anymedia contaminants.
The Shigella cell pellet was resuspended in PBS with a 0.03% Congo red, and
this suspension was incubated at 37C for 15 min to activate the Shigella for
infection. Eachwell was infectedwith 0.1ml ofShigella suspension for infection,
and then the plates were centrifuged at 1,0003 g for 10min to facilitate contact
between bacteria and host cells. The plates were then incubated for 90 min at
37C and 5% CO2. Then the cells were washed three times (1 ml per 12 well)
with PBS and gentamicin (150 mg/mL) to remove any unbound bacteria. After
the third wash, complete DMEMwithout antibiotics was replaced, and infection
continueduntil timepointswere reached.Most interferonmRNAexpressionwas
measured 6–8 hr post-infection. For analysis of proteins in the STING-TBK1-
IRF3 pathway, 10 cm dishes were used. MEFs were plated at 1.5 3 106 per
10 cm plate, and initial dose of Shigella was 1 ml of activated culture.
Microinjection
Microinjection experiments were done as described in Selyunin et al. (2014).
Briefly, microinjections of IpaJD50 and VirAD26 were performed using a
semiautomatic InjectMan NI2 micromanipulator (Eppendorf). Recombinant
proteins were diluted in 1X Tris-buffered saline (TBS) with Cascade Blue (Invi-
trogen) fluorescent dye (2 mg/ml). The final concentration of the proteins was
1 mg/ml. Concentration of DNA was 4 ng/ml.
RNA Isolation and Quantitative RNA Analysis
Total RNA from cells was isolated with TRI reagent according to the manufac-
turer’s instructions (Sigma-Aldrich). RNA quantity and quality were confirmed
with a NanoDrop ND-1000 Spectrophotometer. cDNA was synthesized
from 1 mg of RNA using the iScriptTM Reverse Transcription Supermix for
RT-qPCR (Bio-Rad) per manufacturer’s instructions. iTaqTM Universal SYBR
Green Supermix, and ABI-7500 Fast Real-Time PCR system (Applied Biosci-
ence), and specific gene primers were used for real-time PCR analysis as in
Hasan et al. (2013). The results are presented relative to those of Gapdh.
QIAGEN qPCR Array was used for the generation of the heatmap. The array
plate contains validated primer sets for interferon beta gene (IFN-beta), Inter-
feron stimulated genes (ISGs) (CxCL10, IFIT1, IRF7,OasI2, and ISG15), pro-in-
flammatory genes (IL1-beta, IL1-alpha, IL-6, and CCL2) and housekeeping166 Cell Host & Microbe 18, 157–168, August 12, 2015 ª2015 Elsevigenes (Gapdh, Actin, and HPRT). A heatmap was generated using GENE-E
program (Broad Institute).
Microscopy
For Sting/ MEFs reconstituted with various Sting-rescuing constructs, WT
or mutant Sting-GFP was cloned into retroviral MRX-ibsr vector (Saitoh et al.,
2009) (a kind gift from S. Akira) using EcoRI and Not I sites. Retroviruses were
packaged in 293T cells and used for infection of Sting/ MEFs followed by
selection with blasticidine (Sigma). For microscopy, Sting-GFP MEFs were
grown on cover slides in 12-well plates and transfected with DNA or infected
with bacteria. Cells grown on coverslips were fixed in 4% (wt/vol) paraformal-
dehyde and were permeabilized and stained by standard protocols. Anti-
bodies used for microscopy are mouse or rabbit Calnexin (Abcam), rabbit
ERGIC/p58 (Sigma), mouse anti-GM130 (BD Biosciences), and TBK1 (Ab-
cam). Samples mounted in Vectashield mounting medium containing DAPI
(4,6-diamidino-2-phenylindole; Vector Laboratories) were imaged with a
Zeiss Imager.M2 fluorescence microscope equipped with AxioVision soft-
ware. Colocalization quantification by Pearson’s correlation coefficient was
done in SlideBook 5.0 software.
Reporter Assays
IFN-Luciferase reporter assays were performed as described in Jeremiah et al.
(2014). pGL3-IFN-Luc and MCSV-hSTING plasmids were kind gifts from
Nicolas Manel. STING disease mutations were generated by site-directed
mutagenesis. For the reporter assay, pGL3-IFN-Luc (firefly), CMV-Luc (renilla),
and indicated STINGplasmids were transfected to 293T cells in 24-well plates.
24 hr later, IFN activation wasmeasured by Dual-Luc assay (Promega). To test
how various STING mutants respond to cGAMP, cells were transfected again
with indicated amount of 2030-cGAMP (Invivogen), and IFN activation was
measured 24 hr after transfection.
SDS-PAGE and Western Blot Analysis
Cells were removed from the plate with trypsin (Sigma-Aldrich), and collected
by centrifugation at 500 3 g for 5 min. Cell pellets were washed twice with
equal volumes of PBS to remove any media contaminants. Cell pellet was
lysed with 0.1 ml of 1X RIPA lysis buffer (50 mM Tris [pH 7.5], 150 mM sodium
chloride, 0.5% sodium deoxycholate, and 1%NP-40) containing 1X cOmplete
EDTA-free Protease inhibitor cocktail tablets (Roche Diagnostics), 1X Phos-
phatase Inhibitor Cocktail 2 (Sigma-Aldrich), 1 mM sodium orthovanadate
(Sigma-Aldrich), 25 mM sodium fluoride (Sigma-Aldich), and 1 mM phenylme-
thylsulfonyl fluoride (Sigma-Aldrich). The lysates were centrifuged at 20,0003
g for 20 min at 4C to remove insoluble proteins. Protein concentration
was quantified by using the PierceTM BCA Protein Assay Kit per manufac-
turer’s instructions. 100 mg of total protein was loaded per sample on a 10%
polyacrylamide gel and run at 150V for 1 hr using the Bio-Rad Mini-PROTEAN
Tetra Cell. Proteins from the gel were transferred to nitrocellulose using a
Trans-Blot SD. Semi-Dry Transfer Cell (Bio-Rad) at 15V for 1 hr. Successful
transfer of proteins to the nitrocellulose membrane was confirmed by using
the 1X Red AlertTM Western Blot Stain (Novagen, EMD Millipore). Membranes
blocked with 5% non-fat milk in 1X TBS-T (20 mM Tris Base, 150 mM sodium
chloride, and 0.05%Tween-20 [pH 7.6]). Then themembrane was cut into sec-
tions to allow for primary antibody detection. Primary antibodies used were
rabbit anti-STING (Cell Signaling), rabbit anti-Phospho-TBK1/NAK (Ser172)
(D52C2) XP (Cell Signaling), rabbit anti-Phospho-IRF-3 (Ser396) (4D4G)
(Cell Signaling), and rabbit anti-HMGB2 (Abcam). Antibodies were used per
the manufacturer’s instructions. Portions of the membrane were incubated
overnight at 4C in either TBS-T or 5% non-fat milk in TBS-T at the appropriate
dilutions. Membranes were washed three times for 10 min each at room
temperature. Membranes were incubated with goat anti-rabbit-IgG-HRP-con-
jugated secondary antibody (Bio-Rad) diluted in 5% non-fat milk in TBS-T for
2 hr at room temperature, after which the membranes were washed three
times for 10min each in TBS-T, and SuperSignalWest Pico Chemiluminescent
Substrate (Thermo Scientific) was used to develop the blots on film. The
pTBK1 and pIRF-3 membranes were stripped using Restore Western Blot
Stripping Buffer (Thermo Scientific) per manufacturer’s instructions, and total
TBK1 and total IRF-3 protein was determined by using rabbit anti-TBK1/NAK
(D1B4) (Cell Signaling) and rabbit anti-IRF-3 antibody (a kind gift from Takashi
Fujita) for detection.er Inc.
Membrane Fractionation
Membrane fractionations by differential centrifugation were performed as in
Ge et al. (2013) with the following modification. Five 15-cm plates were com-
bined, and cell pellets were washed one time with PBS to remove any media
contaminants. The cell pellet was resuspended in 200 ml of membrane fraction-
ation buffer (20mMHEPES-NaOH [pH 7.2], 400mM sucrose, and 1mMEDTA)
per 53 106 cells. Cells were lysed by passing the homogenate through a 25G
needle thirty times. Ten percent of the volumewas then retained as a represen-
tation of the total fraction. Homogenates were subjected to sequential centri-
fugations 1,000 3 g (15 min), 3,000 3 g for (15 min), 10,000 3 g (15 min),
25,000 3 g (20 min), 50,000 3 g (20 min), and 100,000 3 g (30 min) using a
Beckman TLA100.3 rotor and ultracentrifuge. Each pellet was washed with
500 ml of membrane fractionation buffer and centrifuged for the same speed
to remove any contaminants.
Statistical Methods
Data are presented as the mean ± SEM. Graphpad Prism 6 was used for
statistical analysis. Statistical tests performed were indicated in figure legend.
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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